Caesars Entertainment
CZR
$29.43
+0.48%
Caesars Entertainment, Inc. is a leading operator in the U.S. gaming and hospitality industry, managing a portfolio of approximately 50 domestic casino resorts across key markets like Las Vegas and regional locations. The company is a dominant market player with iconic brands such as Caesars, Harrah's, and Bally's, and has expanded its presence through acquisitions and a digital sports betting platform via William Hill. The current investor narrative is overwhelmingly dominated by the announced $17.6 billion deal to take the company private by Fertitta Entertainment, which offers shareholders a significant premium and represents a major near-term catalyst, shifting focus from ongoing operational challenges like debt management and digital integration to the completion of this transaction.…
CZR
Caesars Entertainment
$29.43
Related headlines
Investment Opinion: Should I buy CZR Today?
Rating: Hold. The core thesis is that CZR is a merger arbitrage play with defined upside to the buyout price but substantial downside if the deal fails, warranting a neutral stance until greater certainty emerges.
Supporting evidence includes the locked-in 49% premium from the buyout announcement, which is the primary driver of the recent 24.02% YTD return. The stock trades at a low Price-to-Sales multiple of 0.42 and an EV/EBITDA of 9.21x, reflecting its leveraged status rather than growth prospects. While the company generated $520 million in TTM free cash flow, its Return on Equity is deeply negative at -14.33%, and analyst coverage is limited due to the pending transaction, increasing uncertainty.
The two biggest risks are deal failure and the company's unsustainable debt load. This Hold rating would upgrade to a Buy only upon definitive confirmation of deal closure (e.g., shareholder and regulatory approval). It would downgrade to a Sell if the deal is terminated, likely triggering a drop toward the $18 support level. Relative to its own history, the stock is undervalued on a sales basis, but this is justified by the capped upside from the buyout, making it fairly valued in the context of the pending transaction.
Sign up to view all
CZR 12-Month Price Forecast
The 12-month outlook for CZR is almost entirely event-driven, with a high (65%) probability assigned to the bull case of successful deal completion. The base and bear cases account for delays and failure, respectively. The current neutral stance reflects the favorable risk/reward skew if the deal closes, but acknowledges the catastrophic downside if it fails, exacerbated by the company's weak balance sheet. Confidence is medium due to the inherent uncertainties in regulatory approvals and financing for large-scale M&A. The stance would upgrade to bullish upon definitive deal closure confirmation and downgrade to bearish upon any official announcement of material obstacles or termination.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Caesars Entertainment's 12-month outlook, with a consensus price target around $38.26 and implied upside of +30.0% versus the current price.
Average Target
$38.26
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$24 - $38
Analyst target range
Insufficient analyst coverage data is available in the provided dataset to calculate a consensus price target or recommendation distribution. The data indicates only 7 analysts providing estimated EPS and revenue, but no aggregate price targets or buy/hold/sell ratings are presented. This limited coverage, despite the company's size, may be due to the pending acquisition by Fertitta Entertainment, which has rendered traditional equity research less relevant as the stock price is now tethered to the deal's closure. The implications are clear: investment decisions are now almost entirely centered on merger arbitrage dynamics—assessing the probability of deal completion, timing, and the locked-in premium—rather than on fundamental analysis of Caesars as a going concern. The wide range in analyst EPS estimates for the next period, from $0.07 to $1.24, further underscores the high uncertainty surrounding the company's standalone financial trajectory amidst the takeover process.
Bulls vs Bears: CZR Investment Factors
The bullish case is currently stronger, anchored by the concrete, high-premium buyout offer that provides a defined exit and significant upside from pre-announcement levels. The bearish concerns, while severe, are largely mitigated if the transaction completes as planned. The single most important tension in the investment debate is the binary outcome between successful deal closure and deal failure. If the buyout completes, shareholders capture the premium; if it fails, the stock faces a precipitous fall back to levels dictated by its highly leveraged balance sheet and ongoing operational challenges.
Bullish
- Locked-in 49% Premium Buyout: The announced $17.6 billion deal by Fertitta Entertainment offers shareholders a significant 49% cash premium. This provides a clear, near-term price target and has driven the stock's 24.02% YTD surge, making it a compelling merger arbitrage play.
- Strong Technical Momentum: The stock is in a pronounced uptrend, up 19.85% over six months and trading at 92% of its 52-week high of $31.58. Recent momentum is exceptionally strong, with a 6.25% gain over the past month, indicating high conviction in the deal's completion.
- Despite net losses, the company generated $520 million in trailing twelve-month free cash flow. This provides crucial liquidity to service its substantial debt load while the buyout process unfolds.
- Dominant Market Position: As a leading operator with ~50 domestic casino resorts and iconic brands, Caesars holds a dominant position in key markets like Las Vegas (48% of 2025 EBITDAR). This underlying asset value supports the acquisition rationale.
Bearish
- Extremely High Financial Leverage: The balance sheet carries a dangerously high debt-to-equity ratio of 7.52 and a weak current ratio of 0.80. Quarterly interest expense of $577 million in Q4 2025 completely overshadowed operating income, creating severe financial risk if the deal fails.
- Persistent Net Losses: The company posted a Q4 2025 net loss of $250 million, resulting in negative EPS of -$1.23 and a net margin of -8.57%. This unprofitability, driven by high interest costs, makes standalone valuation challenging.
- Deal Completion Risk: The investment thesis is now binary and hinges entirely on the buyout closing. Any regulatory hurdles, financing issues, or market volatility could derail the transaction, exposing the stock to a sharp decline back to fundamental levels.
- Valuation Compression to Historical Lows: The stock trades at a trailing PS ratio of 0.42, far below its historical range where it frequently traded above 1.5x sales. This de-rating reflects the capped upside from the buyout and market skepticism about standalone growth prospects.
CZR Technical Analysis
The stock is in a pronounced recovery and uptrend, having surged 19.85% over the past six months and 24.02% year-to-date, significantly outperforming the S&P 500's 9.51% YTD gain. As of the latest close near $29.22, the price is trading at approximately 92% of its 52-week high of $31.58, indicating strong momentum but also proximity to a key resistance level that could signal overextension if the breakout fails. Recent momentum is exceptionally strong, with the stock up 6.25% over the past month and 9.19% over three months, decisively reversing the weakness seen earlier in the year and diverging positively from the modest 5.30% one-year gain. This acceleration, coupled with a high beta of 1.77, suggests the stock is exhibiting amplified volatility and is highly sensitive to company-specific news, such as the buyout announcement. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $31.58 and support at the 52-week low of $17.86. A confirmed breakout above $31.58 would signal a new bullish phase, while a failure could lead to a pullback. The stock's beta of 1.77 indicates it is roughly 77% more volatile than the broader market, a critical factor for risk-aware investors given the binary outcome of the pending acquisition.
Beta
1.77
1.77x market volatility
Max Drawdown
-42.4%
Largest decline past year
52-Week Range
$18-$32
Price range past year
Annual Return
+3.3%
Cumulative gain past year
| Period | CZR Return | S&P 500 |
|---|---|---|
| 1m | +3.4% | -1.6% |
| 3m | +9.7% | +11.7% |
| 6m | +20.1% | +6.3% |
| 1y | +3.3% | +22.2% |
| ytd | +24.9% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CZR Fundamental Analysis
Revenue growth has been modest but positive, with Q4 2025 revenue of $2.92 billion representing a 4.18% year-over-year increase; however, this marks a deceleration from the stronger growth seen in prior quarters of 2025. The business is heavily driven by its core Casino segment, which generated $1.71 billion in the latest period, alongside contributions from Food and Beverage ($415 million) and Owned Hotels ($469 million). The company is currently unprofitable on a net income basis, posting a Q4 2025 net loss of $250 million, which resulted in negative EPS of -$1.23 and a net margin of -8.57%. While the gross margin was a healthier 37.35%, operating profitability is pressured by significant interest expenses, which totaled $577 million in the quarter, overshadowing the $525 million in operating income. The balance sheet carries substantial financial risk, evidenced by a very high debt-to-equity ratio of 7.52 and a weak current ratio of 0.80, indicating potential liquidity constraints. Positively, the company generated $520 million in trailing twelve-month free cash flow, providing some capacity to service its debt, though the Return on Equity remains deeply negative at -14.33%, reflecting the burden of leverage on shareholder returns.
Quarterly Revenue
$2.9B
2025-12
Revenue YoY Growth
+0.04%
YoY Comparison
Gross Margin
+0.37%
Latest Quarter
Free Cash Flow
$520000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CZR Overvalued?
Given the company's negative net income, the primary valuation metric selected is the Price-to-Sales (PS) ratio. Caesars trades at a trailing PS ratio of 0.42 and an Enterprise Value-to-Sales (EV/Sales) of 2.71, which are low multiples suggesting the market is not assigning a premium for growth. The forward P/E ratio of 34.70x, based on expected positive EPS, indicates the market is pricing in a significant earnings recovery post-acquisition or operational improvement. Compared to sector averages, the stock's EV/EBITDA of 9.21x is a more relevant peer comparison for capital-intensive casinos; this multiple is not provided against an industry benchmark, but historically, a sub-10x EV/EBITDA can be considered moderate for the sector, potentially reflecting the high debt load. Historically, the stock's own valuation has compressed significantly; its current PS ratio of 0.42 is far below its historical range seen over the past few years, where it frequently traded above 1.5x and even above 3x sales. This dramatic de-rating to near historical lows is primarily a function of the pending buyout price, which effectively caps the upside and frames the stock as a merger arbitrage play rather than a reflection of deteriorating fundamentals.
PE
-9.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -249x~163x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and originate from Caesars' capital structure. The debt-to-equity ratio of 7.52 indicates extreme leverage, while the current ratio of 0.80 signals potential liquidity constraints. The company's profitability is crippled by interest expenses, which at $577 million in Q4 2025 were greater than its $525 million operating income, leading to a net margin of -8.57%. This creates a dependency on the buyout to resolve the balance sheet burden, as standalone debt servicing is a significant drag.
Market & Competitive Risks are heightened by the stock's binary event nature. With a beta of 1.77, CZR is 77% more volatile than the market, amplifying price swings on any deal-related news. The valuation has already compressed to a PS ratio of 0.42, near historical lows, indicating the market assigns no growth premium. Competitive and regulatory risks, while always present in gaming, are secondary to the immediate deal completion risk, as evidenced by recent news focusing entirely on M&A dynamics in the sector.
Worst-Case Scenario involves the Fertitta buyout collapsing due to regulatory rejection, financing failure, or a market downturn. In this event, the stock would rapidly re-price based on its strained fundamentals. The realistic downside would be a return to its 52-week low of $17.86, representing a potential loss of approximately -39% from the current price near $29.22. This decline would be exacerbated by the high short interest (short ratio 2.68) and the company's need to refinance debt under distressed conditions.
FAQ
The primary risk is deal completion risk—the buyout could fail due to regulatory, financing, or market conditions, triggering a sharp decline. Financial risk is severe, with a debt-to-equity ratio of 7.52 and a weak current ratio of 0.80, indicating high leverage and liquidity constraints. Operational risk persists, as the company is unprofitable (Q4 net margin -8.57%) due to massive interest expenses. Finally, market risk is elevated due to the stock's high beta of 1.77, making it more volatile than the market on any deal-related news.
The forecast is bifurcated around the $17.6 billion buyout. The bull case (65% probability) targets $31.58 to $34 upon successful deal closure. The base case (25%) sees the stock trading between $26 and $29 amid minor deal delays. The bear case (10%) forecasts a drop to the $17.86 to $22 range if the deal collapses. The most likely scenario is the bull case, as the significant premium and strategic rationale make deal completion probable, but the timeline and final terms carry uncertainty.
CZR's valuation is event-contingent, not fundamental. On a standalone basis, its trailing Price-to-Sales ratio of 0.42 and EV/EBITDA of 9.21x appear low, potentially undervalued compared to its historical range. However, this compression reflects the capped upside from the buyout. The forward P/E of 34.70x prices in an earnings recovery, but this is irrelevant if the company goes private. The stock is fairly valued relative to the near-certainty of the acquisition, trading at a slight discount to the offer price that reflects the remaining execution risk.
CZR can be a good buy for a specific type of investor: those engaged in merger arbitrage who are comfortable with binary outcomes. The stock offers a defined upside to the ~$31.58 buyout price from the current ~$29.22 level, representing a ~8% return if the deal closes. However, the key risk is deal failure, which could see the stock fall ~39% to its 52-week low of $17.86, given its high debt load (Debt/Equity of 7.52) and recent net losses. It is not suitable for long-term fundamental investors seeking growth or income.
CZR is strictly a short- to medium-term event-driven investment, with a horizon tied directly to the buyout's expected closing timeline (likely 6-12 months). It is unsuitable for long-term holding due to its binary outcome; once the deal closes, the stock will be delisted. If the deal fails, long-term holders would be stuck with a highly leveraged company facing significant operational challenges. The high beta of 1.77 also makes it unsuitable for low-volatility, buy-and-hold portfolios. The suggested minimum holding period is zero—it is a tactical trade, not a long-term investment.